Qualigen therapeutics, inc. reports third quarter 2021 financial results

Carlsbad, calif., nov. 15, 2021 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a biotechnology company focused on developing novel therapeutic products for the treatment of adult and pediatric patients with rare cancers, as well as maintaining and expanding its flagship fastpack® diagnostic platform, today announced its financial results for the third quarter and nine months ended september 30, 2021.
QLGN Ratings Summary
QLGN Quant Ranking